Cel AI PLC Cash Flow Conversion Efficiency
Cel AI PLC cash flow conversion efficiency. Based on the latest financial reports, Cel AI PLC (CLAI) has a cash flow conversion efficiency ratio of -0.598x as of August 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-307.67K ≈ $-37.43 USD) by net assets (GBX514.55K ≈ $62.61 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Cel AI PLC (2019–2024)
Cash flow conversion efficiency of Cel AI PLC from 2019 to 2024. This chart illustrates how Cel AI PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. View CLAI stock price and chart for real-time trading data and today's change.
Cel AI PLC Cash Flow Conversion Ratio Explained
Cel AI PLC cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Cel AI PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cel AI PLC ranked by their cash flow conversion efficiency. Also see Cel AI PLC (CLAI) total market value for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
XTC Lithium Limited
AU:XTC
|
-0.140x |
|
Predator Oil & Gas Holdings Plc
LSE:PRD
|
-0.067x |
|
Next Technology Holding Inc
NASDAQ:NXTT
|
-0.001x |
|
EARNZ plc
LSE:EARN
|
-0.135x |
|
Mondee Holdings Inc.
NASDAQ:MONDQ
|
-1.846x |
|
Mobilityone Ltd
LSE:MBO
|
0.906x |
|
Stardust Power Inc.
NASDAQ:SDST
|
0.235x |
|
Abacus Global Management, Inc.
NASDAQ:ABX
|
-0.075x |
Annual Cash Flow Conversion Efficiency for Cel AI PLC (2019–2024)
The table below shows the annual cash flow conversion efficiency of Cel AI PLC from 2019 to 2024. Review Cel AI PLC financial flexibility index to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-08-31 | GBX514.55K ≈ $62.61 |
GBX-1.10 Million ≈ $-133.96 |
-2.140x | -84.37% |
| 2023-08-31 | GBX2.26 Million ≈ $275.32 |
GBX-2.63 Million ≈ $-319.51 |
-1.161x | +5.70% |
| 2022-08-31 | GBX4.85 Million ≈ $590.38 |
GBX-5.97 Million ≈ $-726.54 |
-1.231x | -372.55% |
| 2021-08-31 | GBX10.55 Million ≈ $1.28K |
GBX-2.75 Million ≈ $-334.22 |
-0.260x | -111.61% |
| 2020-08-31 | GBX-83.24K ≈ $-10.13 |
GBX-186.78K ≈ $-22.73 |
2.244x | +334.98% |
| 2019-08-31 | GBX55.37K ≈ $6.74 |
GBX-52.88K ≈ $-6.43 |
-0.955x | -- |
About Cel AI PLC
Cel AI PLC, together with its subsidiaries, engages in the manufacture and sale of biosynthetic cannabinoids-based consumer products in the United Kingdom. The company provides cannabinoid solutions for skincare products. The company was formerly known as Cellular Goods PLC and changed its name to Cel AI PLC in February 2024. Cel AI PLC was incorporated in 2018 and is based in London, United King… Read more